Currency: GBP
Period
FY2023 Annual Report
--
381.00K
-8.00
No Data
Revenue
EPS
EBIT
Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Biodexa Pharmaceuticals | 20-F: Registration statement / Annual report / Transition report
Apr 20 00:49
Biodexa Pharmaceuticals | 6-K: Report of foreign private issuer (related to financial reporting)
Apr 19 20:23
Dec 22, 2023 05:30
Nov 27, 2023 21:45
Read more